Chevron icon It indicates an expandable section or menu, or sometimes previous / next navigation options. HOMEPAGE

Bankrupt poop-testing startup uBiome was banking on CVS selling its tests — but the chain just turned it down

ubiome 3
A uBiome Explorer test kit. Erin Brodwin

  • CVS has decided not to stock uBiome's sole remaining product, an at-home microbiome test called Explorer.
  • uBiome was counting on selling the kits in CVS stores as part of a plan to get a fresh start and show it still has value.
  • "Given the circumstances surrounding uBiome, we'll be stopping shipments and, in the event product has already arrived in store, marking it as 'do not sell,'" a CVS spokesperson said.
  • uBiome filed for bankruptcy yesterday amid refund demands from health insurers and potential fines from ongoing civil and criminal investigations.
  • Click here for more BI Prime stories.

The poop-testing startup uBiome is facing yet another setback a day after filing for bankruptcy.

The massive pharmacy chain CVS Health has decided it won't stock uBiome's testing kits in its stores, according to a CVS spokesman. uBiome was counting on selling the kits in CVS stores as part of a plan to get a fresh start and demonstrate to potential acquirers that the company still has value.

"Simply put, uBiome needs a clean slate and a fresh start to save the business and 100 jobs," uBiome acting CEO Curtis Solsvig said in a court document.

uBiome didn't immediately respond to a request for comment.

The company said in its bankruptcy filing that it hoped to entice an investor to purchase it for its scientific knowledge of the microbiome, the trillions of bacteria that live in and on our bodies. uBiome said it had approached 180 potential acquirers but couldn't seal a deal. Potential uBiome buyers face risks that include civil and criminal penalties resulting from ongoing investigations into uBiome's business practices, the document said.

"Given the circumstances surrounding uBiome, we'll be stopping shipments and, in the event product has already arrived in store, marking it as 'do not sell,'" TJ Crawford, a CVS spokesman, told Business Insider by email.

Read more: uBiome convinced Silicon Valley that testing poop was worth $600 million. Then the FBI came knocking. Here's the inside story.

The company has been in hot water for several months. The startup's problems burst into public view after an FBI raid in April. uBiome is under federal investigation in relation to its billing practices, and it laid off half its staff earlier this summer.

In addition, insiders told Business Insider that key science was flawed from the start, prompting the company to start an internal investigation. A top science journal where uBiome published its basic research is also investigating.

The kits that uBiome planned to sell at CVS stores are known as the Explorer. uBiome also sells them on its website for $89. To take an Explorer test, you get a sample of your poop at home and send it to uBiome for analysis.

Then you get back an online report comparing the bacteria in your gut with that of other uBiome volunteers in the company's database. The company says that the results aren't supposed to be used to diagnose or treat diseases.

In previous years, uBiome sold two other kits that it marketed as clinical products. Sales of those two tests, called SmartGut and SmartJane, were halted this summer as a result of the FBI probe.

Health Healthcare Dispensed

Jump to

  1. Main content
  2. Search
  3. Account